Picture EBD Group BioTech Showcase 2020 San Francisco BEU2020 650x76px

Person › Details

Ugur Sahin (BioNTech AG)

Sahin, Ugur (BioNTech 201207 Managing Director BioNTech + Ribological GmbH)

	Organisation	BioNTech AG
	Today	BioNTech SE (Nasdaq: BNTX)
	Group	BioNTech (Group)
	Former/major organisation	Ribological GmbH
	Today	BioNTech RNA Pharmaceuticals GmbH
	Group	BioNTech (Group)
	Product	drug discovery
	Product 2	cancer drug
	Source	4SC AG. (7/17/12). "Press Release: 4SC Discovery, Crelux and Ribological Launch Collaboration for the Discovery and Optimisation of New Anti-cancer Drugs [no US". Planegg-Martinsried.

Record changed: 2019-09-05

Picture [LSA] Life-Sciences-Asia.com – The Business Web Portal 650x89px

More documents for Ugur Sahin

[1] Grover, Natalie [Endpoints]. (9/10/19). "News: Hong Kong Strife Holds Up almost $100m of BioNTech's Series B Haul"....
[2] BioNTech SE. (9/4/19). "Press Release: BioNTech Announces New Collaboration to Develop HIV and Tuberculosis Programs". Mainz....
[3] BioNTech SE. (7/9/19). "Press Release: BioNTech Raises USD 325 Million in an Upsized Series B Financing to Further Advance Individualized Immuno-Oncology Pipeline". Mainz....
[4] BioNTech SE. (5/8/19). "Press Release: BioNTech Acquires MabVax Therapeutics’ Antibody Assets to Expand Portfolio". Mainz....
[5] BioNTech AG. (1/23/19). "Press Release: BioNTech to Acquire Antibody Generation Unit of MAB Discovery". Mainz & Munich....
[6] BioNTech AG. (1/4/19). "Press Release: Sanofi Invests EUR 80m (approx. USD 91.5m) in BioNTech as Partners Extend Collaboration and Advance mRNA-based Cancer Immunotherapy into Clinical Testing against Multiple Solid Tumors". Mainz....
[7] BioNTech AG. (11/5/18). "Press Release: BioNTech and the University of Pennsylvania Enter into Strategic Research Collaboration to Develop mRNA Vaccine Candidates against Various Infectious Diseases". Mainz....
[8] BioNTech AG. (8/16/18). "Press Release: BioNTech Signs Collaboration Agreement with Pfizer to Develop mRNA-based Vaccines for Prevention of Influenza". Mainz & New York, NY....
[9] BioNTech AG. (7/10/18). "Press Release: BioNTech and Genevant Sciences Sign Strategic mRNA-Focused Partnership in Rare Diseases". Mainz, Cambridge, MA & Basel....
[10] BioNTech AG. (1/4/18). "Press Release: BioNTech Secures USD 270 Million in Series A Financing". Mainz....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

» top